$IDIX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in IDENIX PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in IDENIX PHARMACEUTICALS INC. Get notifications about new insider transactions in IDENIX PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 23 2012	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.78	997	2,772	33,276,369	33.3 M to 33.3 M (0.00 %)
Feb 23 2012	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.69	997	2,682	33,275,372	33.3 M to 33.3 M (0.00 %)
Feb 23 2012	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.56	2,493	6,382	33,274,375	33.3 M to 33.3 M (+0.01 %)
Feb 23 2012	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.47	366	904	33,271,882	33.3 M to 33.3 M (0.00 %)
Feb 23 2012	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	35,735	86,121	33,271,516	33.2 M to 33.3 M (+0.11 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	5.46	9,197	50,216	33,235,781	33.2 M to 33.2 M (+0.03 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	5.11	2,107	10,767	33,226,584	33.2 M to 33.2 M (+0.01 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	4.70	20,228	95,072	33,224,477	33.2 M to 33.2 M (+0.06 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.79	140	531	33,204,189	33.2 M to 33.2 M (0.00 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.17	1,146	3,633	33,204,049	33.2 M to 33.2 M (0.00 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.95	6,476	19,104	33,202,903	33.2 M to 33.2 M (+0.02 %)
Nov 22 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	11,236	27,079	33,196,427	33.2 M to 33.2 M (+0.03 %)
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	4.57	20,000	91,400	20,000
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	HOWSON TAMAR D	Director	Option Exercise	A	4.57	20,000	91,400	20,000
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	4.57	20,000	91,400	20,000
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	4.57	20,000	91,400	20,000
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	4.57	20,000	91,400	20,000
Jun 03 2011	IDIX	IDENIX PHARMACEUTI ...	Beckman Daniella	VP, CFO and Treasur ...	Option Exercise	A	4.57	50,000	228,500	50,000
Apr 13 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.80	1,785,714	4,999,999	33,185,191	31.4 M to 33.2 M (+5.69 %)
Feb 25 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	5.11	206	1,053	31,399,477	31.4 M to 31.4 M (0.00 %)
Feb 25 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.88	1,760	6,829	31,399,271	31.4 M to 31.4 M (+0.01 %)
Feb 25 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.79	860	3,259	31,397,551	31.4 M to 31.4 M (0.00 %)
Feb 25 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.96	897	2,655	31,396,651	31.4 M to 31.4 M (0.00 %)
Feb 25 2011	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	17,270	41,621	31,395,754	31.4 M to 31.4 M (+0.06 %)
Feb 23 2011	IDIX	IDENIX PHARMACEUTI ...	Stahl Maria D	SVP & General Couns ...	Option Exercise	A	3.17	80,000	253,600	80,000
Feb 23 2011	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP & Chief Scienti ...	Option Exercise	A	3.14	125,000	392,500	125,000
Feb 23 2011	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	President & CEO	Option Exercise	A	3.14	300,000	942,000	300,000
Feb 23 2011	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Option Exercise	A	3.17	60,000	190,200	60,000
Feb 23 2011	IDIX	IDENIX PHARMACEUTI ...	Fanning Paul	SVP, Human Resource ...	Option Exercise	A	3.17	40,000	126,800	40,000
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	5.46	486	2,654	31,378,484	31.4 M to 31.4 M (0.00 %)
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	5.11	1,332	6,807	31,377,998	31.4 M to 31.4 M (0.00 %)
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.79	165	625	31,376,666	31.4 M to 31.4 M (0.00 %)
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.96	44	130	31,376,501	31.4 M to 31.4 M (0.00 %)
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.64	822	2,170	31,376,457	31.4 M to 31.4 M (0.00 %)
Nov 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	14,234	34,304	31,375,635	31.4 M to 31.4 M (+0.05 %)
Nov 01 2010	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Executive Off ...	Option Exercise	A	4.28	300,000	1,284,000	300,000
Oct 13 2010	IDIX	IDENIX PHARMACEUTI ...	Stahl Maria D	SVP & General Couns ...	Option Exercise	A	3.87	150,000	580,500	150,000
Aug 23 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.79	813	3,081	31,361,401	31.4 M to 31.4 M (0.00 %)
Aug 23 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	3.04	91	277	31,360,588	31.4 M to 31.4 M (0.00 %)
Aug 23 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.96	262	776	31,360,497	31.4 M to 31.4 M (0.00 %)
Aug 23 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	36,048	86,876	31,360,235	31.3 M to 31.4 M (+0.12 %)
Jun 08 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	1,351	3,256	31,324,187	31.3 M to 31.3 M (0.00 %)
Jun 04 2010	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Jun 04 2010	IDIX	IDENIX PHARMACEUTI ...	HOWSON TAMAR D	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Jun 04 2010	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Jun 04 2010	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Jun 04 2010	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Apr 15 2010	IDIX	IDENIX PHARMACEUTI ...	Fanning Paul	SVP, Human Resource ...	Option Exercise	A	2.96	35,000	103,600	35,000
Apr 01 2010	IDIX	IDENIX PHARMACEUTI ...	HOWSON TAMAR D	Director	Option Exercise	A	2.79	3,333	9,299	3,333
Apr 01 2010	IDIX	IDENIX PHARMACEUTI ...	HOWSON TAMAR D	Director	Option Exercise	A	2.79	15,000	41,850	15,000
Feb 26 2010	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	1,872	4,512	31,322,836	31.3 M to 31.3 M (+0.01 %)
Feb 11 2010	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP, Biology	Option Exercise	A	2.96	50,000	148,000	50,000
Feb 11 2010	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	2.96	100,000	296,000	100,000
Feb 11 2010	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	2.96	400,000	1,184,000	400,000
Feb 11 2010	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Option Exercise	A	2.96	100,000	296,000	100,000
Feb 11 2010	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Option Exercise	A	2.96	40,000	118,400	40,000
Dec 17 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Buy	P	2.12	10,387	22,020	57,200	46.8 K to 57.2 K (+22.19 %)
Dec 17 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Buy	P	2.15	15,000	32,250	46,813	31.8 K to 46.8 K (+47.15 %)
Dec 14 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Buy	P	2.12	11,000	23,320	31,813	20.8 K to 31.8 K (+52.85 %)
Dec 14 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Buy	P	2.08	8,613	17,915	20,813	12.2 K to 20.8 K (+70.60 %)
Dec 14 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Buy	P	2.05	5,000	10,250	12,200	7.2 K to 12.2 K (+69.44 %)
Nov 24 2009	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Buy	P	1.89	20,000	37,800	35,000	15 K to 35 K (+133.33 %)
Nov 13 2009	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP, Biology	Option Exercise	M	1.00	15,000	15,000	0
Nov 13 2009	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP, Biology	Buy	M	1.00	15,000	15,000	67,375	52.4 K to 67.4 K (+28.64 %)
Aug 24 2009	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	3,431	8,269	31,320,824	31.3 M to 31.3 M (+0.01 %)
Jun 03 2009	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	3.49	20,000	69,800	20,000
Jun 03 2009	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	3.49	20,000	69,800	20,000
Jun 03 2009	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	3.49	20,000	69,800	20,000
Jun 03 2009	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	3.49	20,000	69,800	20,000
Jun 03 2009	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	3.49	20,000	69,800	20,000
May 29 2009	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.62	2,451	6,422	31,317,393	31.3 M to 31.3 M (+0.01 %)
Feb 23 2009	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	2.41	5,444	13,120	31,314,942	31.3 M to 31.3 M (+0.02 %)
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	5.46	90,000	491,400	90,000
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Option Exercise	A	5.46	110,000	600,600	110,000
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP, Biology	Option Exercise	A	5.46	45,000	245,700	45,000
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Option Exercise	A	5.46	40,000	218,400	40,000
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Fanning Paul	SVP, Human Resource ...	Option Exercise	A	5.46	30,000	163,800	30,000
Feb 18 2009	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	5.46	400,000	2,184,000	400,000
Nov 25 2008	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG		Buy	P	4.05	4,747	19,225	31,309,498	31.3 M to 31.3 M (+0.02 %)
Sep 17 2008	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Sell	J	8.00	110,000	880,000	2,058,569	2.2 M to 2.1 M (-5.07 %)
Sep 03 2008	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Buy	P	2.93	4,654	13,636	31,304,751	31.3 M to 31.3 M (+0.01 %)
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	6.71	20,000	134,200	20,000
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	6.71	20,000	134,200	20,000
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	PAYSON NORMAN C MD	Director	Option Exercise	A	6.71	20,000	134,200	20,000
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	6.71	20,000	134,200	20,000
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	6.71	20,000	134,200	20,000
Jun 04 2008	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	6.71	20,000	134,200	20,000
May 30 2008	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Buy	P	2.41	924	2,227	31,300,097	31.3 M to 31.3 M (0.00 %)
Mar 13 2008	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Buy	P	0.00	15,000	0	15,000	0 to 15 K
Mar 13 2008	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Buy	P	4.45	30,000	133,500	30,000	0 to 30 K
Mar 11 2008	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Buy	P	0.00	15,000	0	15,000	0 to 15 K
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Fanning Paul	SVP, Human Resource ...	Option Exercise	A	5.18	40,000	207,200	40,000
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Option Exercise	A	5.18	80,000	414,400	80,000
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	5.18	60,000	310,800	60,000
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Standring David	EVP, Biology	Option Exercise	A	5.18	70,000	362,600	70,000
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Option Exercise	A	5.18	80,000	414,400	80,000
Feb 26 2008	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	5.18	350,000	1,813,000	350,000
Nov 14 2007	IDIX	IDENIX PHARMACEUTI ...	Mayers Douglas L	EVP and Chief Medic ...	Option Exercise	A	2.41	40,000	96,400	40,000
Nov 14 2007	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	2.41	100,000	241,000	100,000
Nov 14 2007	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	2.41	40,000	96,400	40,000
Nov 14 2007	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Option Exercise	A	2.41	40,000	96,400	40,000
Jul 19 2007	IDIX	IDENIX PHARMACEUTI ...	Koppy Susan	Sr. VP, Business an ...	Buy	P	3.84	400	1,536	650	250 to 650 (+160.00 %)
Jul 02 2007	IDIX	IDENIX PHARMACEUTI ...	Renaud Ronald C JR	Chief Financial Off ...	Option Exercise	A	6.12	225,000	1,377,000	225,000
Jun 04 2007	IDIX	IDENIX PHARMACEUTI ...	Macdonald Guy	Executive VP, Opera ...	Option Exercise	A	7.24	125,000	905,000	125,000
Jun 04 2007	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	7.24	150,000	1,086,000	150,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	PAYSON NORMAN C MD	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Jun 01 2007	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	7.33	20,000	146,600	20,000
Mar 30 2007	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	7.25	150,000	1,087,500	150,000
Mar 20 2007	IDIX	IDENIX PHARMACEUTI ...	Koppy Susan	Sr. VP, Business an ...	Option Exercise	A	8.12	30,000	243,600	30,000
Mar 19 2007	IDIX	IDENIX PHARMACEUTI ...	Macdonald Guy	Executive VP, Opera ...	Option Exercise	A	8.12	40,000	324,800	40,000
Mar 14 2007	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	8.12	10,000	81,200	10,000
Mar 14 2007	IDIX	IDENIX PHARMACEUTI ...	Arkowitz David	Chief Financial Off ...	Option Exercise	A	8.12	40,000	324,800	40,000
Dec 07 2006	IDIX	IDENIX PHARMACEUTI ...	PAYSON NORMAN C MD	Director	Option Exercise	A	9.52	10,000	95,200	10,000
Dec 07 2006	IDIX	IDENIX PHARMACEUTI ...	PAYSON NORMAN C MD	Director	Option Exercise	A	9.52	15,000	142,800	15,000
Sep 06 2006	IDIX	IDENIX PHARMACEUTI ...	Weidenbruch John	Ex. VP, Gen. Counse ...	Option Exercise	A	10.25	75,000	768,750	75,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 16 2006	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	8.85	20,000	177,000	20,000
Jun 08 2006	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Buy	P	20.48	365	7,475	31,299,173	31.3 M to 31.3 M (0.00 %)
May 11 2006	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Buy	P	9.13	10,000	91,300	2,058,269	2 M to 2.1 M (+0.49 %)
May 10 2006	IDIX	IDENIX PHARMACEUTI ...	Koppy Susan	Sr. VP, Business an ...	Buy	P	9.26	200	1,852	250	50 to 250 (+400.00 %)
Apr 06 2006	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Buy	P	16.23	2,938	47,684	31,298,808	31.3 M to 31.3 M (+0.01 %)
Mar 09 2006	IDIX	IDENIX PHARMACEUTI ...	Brown Nathaniel	Chief Medical Offic ...	Option Exercise	A	21.11	30,000	633,300	30,000
Mar 09 2006	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	21.11	150,000	3,166,500	150,000
Mar 09 2006	IDIX	IDENIX PHARMACEUTI ...	Macdonald Guy	Executive VP, Opera ...	Option Exercise	A	21.11	30,000	633,300	30,000
Mar 09 2006	IDIX	IDENIX PHARMACEUTI ...	Arkowitz David	Chief Financial Off ...	Option Exercise	A	21.11	30,000	633,300	30,000
Mar 09 2006	IDIX	IDENIX PHARMACEUTI ...	Corcoran Andrea	Exec. VP, Legal and ...	Option Exercise	A	21.11	30,000	633,300	30,000
Jan 20 2006	IDIX	IDENIX PHARMACEUTI ...	Koppy Susan	Sr. VP, Business an ...	Option Exercise	A	20.16	75,000	1,512,000	75,000
Nov 16 2005	IDIX	IDENIX PHARMACEUTI ...	Pollard-Knight Denise	Director	Sell	S	20.61	629,498	12,973,954	301,476	931 K to 301.5 K (-67.62 %)
Nov 02 2005	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Buy	P	20.61	3,939,131	81,185,490	31,295,870	27.4 M to 31.3 M (+14.40 %)
Sep 07 2005	IDIX	IDENIX PHARMACEUTI ...	NOVARTIS AG	10% Owner	Grant	A	20.18	1,187,093	23,955,537	27,356,739	26.2 M to 27.4 M (+4.54 %)
Jun 09 2005	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	18.88	20,000	377,600	20,000
Jun 09 2005	IDIX	IDENIX PHARMACEUTI ...	HODGSON THOMAS R	Director	Option Exercise	A	18.88	20,000	377,600	20,000
Jun 09 2005	IDIX	IDENIX PHARMACEUTI ...	HOCKMEYER WAYNE T	Director	Option Exercise	A	18.88	20,000	377,600	20,000
Jun 09 2005	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	18.88	20,000	377,600	20,000
May 18 2005	IDIX	IDENIX PHARMACEUTI ...	Thomas-Graham Pamela	Director	Option Exercise	A	20.28	15,000	304,200	15,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Macdonald Guy	Executive VP, Opera ...	Option Exercise	A	19.14	30,000	574,200	30,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Egan James	Sr. VP, Business De ...	Option Exercise	A	19.14	30,000	574,200	30,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Sommadossi Jean-Pierre	President, CEO, Cha ...	Option Exercise	A	19.14	150,000	2,871,000	150,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	CRAMB CHARLES W JR	Director	Option Exercise	A	19.14	10,000	191,400	10,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Corcoran Andrea	Exec. VP, Legal and ...	Option Exercise	A	19.14	30,000	574,200	30,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Brown Nathaniel	Chief Medical Offic ...	Option Exercise	A	19.14	30,000	574,200	30,000
Mar 02 2005	IDIX	IDENIX PHARMACEUTI ...	Arkowitz David	Chief Financial Off ...	Option Exercise	A	19.14	30,000	574,200	30,000

Page: < prev 1 2 3 next >